Health Condition 1: N183- Chronic kidney disease, stage 3 (moderate)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Subjects with classical symptoms of CHRONIC KIDNEY DISEASE having the clinical features like Oedema Pruritis Generalized weakness Nausea etc. GFR (30-100ml/min per 1.73m2) Albuminuria Serum creatinine (0.5-6mg/dl) Blood urea (10-60mg/dl) Mild Hypertension. Subjects of both the genders. Subjects belonging to age group between 20- 60 years of age.
Exclusion criteria
Exclusion criteria: Subjects who donâ??t fulfill the inclusion criteria will be excluded from the study. CKD subjects of stage-4 & stage-5 are excluded. Subjects who are on dialysis therapy. Subjects suffering from Hepatitis/HIV/VDRL will be excluded. Uncontrolled DM. Hypertension above 180/110mm of Hg. Pregnant & Lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Oedema. Pruritis. Nausea. Generalized weakness. Pallor Timepoint: At the end of the 60 days clinical trial. | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum creatinine. Hb%. Urine for Albumin. Blood urea. GFR. Blood Pressure. Timepoint: At the end of 60 days of clinical trial. | — |
Countries
India
Contacts
Ayurveda Mahavidyalaya And Hospital